跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salbustan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salbustan
Approved
STANDARD
Salbustan
J.M. Tolmann Laboratories Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
463ee6e19bc83118
Company
J.M. Tolmann Laboratories Inc
Type
Standard
Approval Details
Approval Id
463ee6e19bc83118
Drug Approval Philippines Name
Salbustan
Product Name
Salbustan
Registration Number
DRP-885-09
Brand Name
Salbustan
Generic Name
Salbutamol (as Sulfate)
Dosage Form
Syrup
Dosage Strength
2 mg/5 mL
Manufacturer
J.M. Tolmann Laboratories Inc
Distributor
Westfield Pharmaceutical, Inc
Issuance Date
26 September 2023
Expiry Date
29 November 2025
Pharmacologic Category
Selective Beta-2-Adrenoreceptor Agonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
463ee6e19bc83118
Type
Standard
Back to Philippines FDA Approvals